This brand name is authorized in Australia, Austria, Brazil, Croatia, Estonia, Finland, France, Ireland, Israel, Italy, Lithuania, Netherlands, New Zealand, Poland, Romania, Spain, Turkey, UK.
The drug LONQUEX contains one active pharmaceutical ingredient (API):
1
|
UNII
4AWF0N6QV3 - LIPEGFILGRASTIM
|
|
Lipegfilgrastim is a sustained duration form of filgrastim due to decreased renal clearance. Lipegfilgrastim binds to human the G-CSF receptor like filgrastim and pegfilgrastim. Human G-CSF is a glycoprotein that regulates the production and release of functional neutrophils from the bone marrow. |
|
Below package inserts are available for further reading:
| Document | Type | Information Source | |
|---|---|---|---|
| LONQUEX Solution for injection in pre-filled syringe | MPI, EU: SmPC | European Medicines Agency (EU) |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| L03AA14 | L Antineoplastic and immunomodulating agents → L03 Immunostimulants → L03A Immunostimulants → L03AA Colony stimulating factors | |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| AU | Pharmaceutical Benefits Scheme | 10931H, 10936N |
| BR | Câmara de Regulação do Mercado de Medicamentos | 537515080006702 |
| EE | Ravimiamet | 1621763 |
| ES | Centro de información online de medicamentos de la AEMPS | 113856001 |
| FI | Lääkealan turvallisuus- ja kehittämiskeskus | 559551 |
| FR | Base de données publique des médicaments | 64198267 |
| GB | Medicines & Healthcare Products Regulatory Agency | 241107 |
| IE | Health Products Regulatory Authority | 88171 |
| IL | מִשְׂרַד הַבְּרִיאוּת | 7617 |
| IT | Agenzia del Farmaco | 042919011, 042919023, 042919047, 042919050 |
| LT | Valstybinė vaistų kontrolės tarnyba | 1071089, 1071090 |
| NL | Z-Index G-Standaard, PRK | 110450 |
| NZ | Medicines and Medical Devices Safety Authority | 19024 |
| PL | Rejestru Produktów Leczniczych | 100300779 |
| RO | Agenția Națională a Medicamentului și a Dispozitivelor Medicale | W65723001, W65723002 |
| TR | İlaç ve Tıbbi Cihaz Kurumu | 8699638955374 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.